Evidence map›Paper›PMID 29785620›Full record

ArticleInternational journal of clinical oncology2018

How asymptomatic are early cancer patients of five organs based on registry data in Japan.

Narue Nakabayashi, Masahiro Hirose, Ritsuro Suzuki, Junji Suzumiya, Mikio Igawa

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. iScience · 2026
    Article
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Narue NakabayashiMedical Services Division, Faculty of Medicine, Shimane University, 89-1 Enya-Chou, Izumo, Shimane, 693-8501, Japan.
Masahiro HiroseDepartment of Community-Based Health Policy and Quality Management, Faculty of Medicine, Shimane University, 89-1 Enya-Chou, Izumo, Shimane, 693-8501, Japan. mhirose@med.shimane-u.ac.jp.ORCID http://orcid.org/0000-0003-1744-046X
Ritsuro SuzukiCenter of Clinical Research, Shimane University Hospital, 89-1 Enya-Chou, Izumo, Shimane, 693-8501, Japan.
Junji SuzumiyaCenter for Innovative Cancer Therapy, Shimane University Hospital, 89-1 Enya-Chou, Izumo, Shimane, 693-8501, Japan.
Mikio IgawaShimane University Hospital, 89-1 Enya-Chou, Izumo, Shimane, 693-8501, Japan.
Shimane University Hospital · JPShimane University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOne reason for the low cancer screening rate in Japan is that people are not concerned about cancer if they do not have symptoms.

methodsThe authors retrospectively analyzed 18,405 cancer patients using hospital-based cancer registry data collected between 2007 and 2013 at the 13 hospitals of Shimane Prefecture, Japan. The symptomatic rates of five cancers (stomach, colorectal, lung, breast, and cervix) at each stage and the time of early diagnosis were investigated. The early detection rates of symptomatic and asymptomatic individuals were investigated.

resultsThe percentages of symptomatic cases tended to increase with progressive stages. The odds ratio (OR) of stage IV compared with that of stage I was 12.23 for stomach, 7.21 for colorectal, 16.91 for lung, 10.30 for breast, and 51.62 for cervical cancer. The proportions of early symptomatic cases at the time of diagnosis were low. Compared with the percentage of early symptomatic cases of stomach cancer of 25.5%, the percentage of lung cancer was the lowest, at 8.2% (OR 0.26), and the percentage of breast cancer was the highest, at 30.2% (OR 1.26). The percentages of early symptomatic cases of colorectal and cervical cancer were 18.9% (OR 0.68) and 19.9% (OR 0.73), respectively. The early detection rates of the asymptomatic and symptomatic groups were 77.6 and 36.1%, respectively.

conclusionCancer registry data indicate that early cancers are asymptomatic, and once symptoms appear, treatment may not be effective. Policy makers should inform people of the necessity of cancer screening before they have symptoms.

Indexed as

Early Detection of CancerSeverity of Illness IndexBreast NeoplasmsColorectal NeoplasmsDatabases, FactualFemaleHumansJapanLung NeoplasmsRegistriesRetrospective StudiesStomach NeoplasmsUterine Cervical NeoplasmsCancer screeningCancer stageHospital-based cancer registrySymptomatic rate

Identifiers

PMID29785620
OpenAlexW2804672322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.